Brief: Bioxyne Qtrly Group Revenue About A$2.1 MLN, Up 75%
31/10/2023 07:29
Oct 31 (Reuters) - Bioxyne Ltd BXN.AX :
* QTRLY GROUP REVENUE ABOUT A$2.1 MILLION, UP 75%
Source text for Eikon: ID:nASX7fj0r
Further company coverage: BXN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BLS Pharmaceuticals
See all newsBrief: BLS Pharmaceuticals Posts Q1 FY27 Revenue A$26.7M
Brief: BLS Pharmaceuticals Reports Record Q1 FY27 Revenue Of A$26.7 Million
Australia's BLS Pharmaceuticals extends gains on upbeat outlook, strong results
Brief: BLS Pharmaceuticals Sees FY27 Adjusted. EBITDA Margin 23% - 26%
Brief: BLS Pharmaceuticals Posts FY Net Profit After Tax Of A$15.4 MLN